WINNING STRATEGIES WASHINGTON for GENENTECH INC (FORMERLY KNOWN AS HOFFMAN-LA ROCHE INC)
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEX DELPIZZO | — |
| DONNA MULLINS | — |
| ROBERT ZUCKER | — |
Budget/Appropriations BUD
FY13 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs, hepatitis screening, care and treatment, and access to breast cancer treatment.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEX DELPIZZO | — |
| DONNA MULLINS | — |
| ROBERT ZUCKER | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| F. HOFFMAN-LA ROCHE LTD. | Switzerland | Switzerland | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.